Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?
Anemia is common in patients with chronic kidney disease (CKD) and is mainly caused by insufficient production of erythropoietin from fibrotic kidney. Because anemia impairs quality of life and overall prognosis, recombinant human erythropoietin-related products (erythropoiesis-stimulating agents, E...
| Auteurs principaux: | , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
The Korean Society of Nephrology
2023-01-01
|
| Collection: | Kidney Research and Clinical Practice |
| Sujets: | |
| Accès en ligne: | http://krcp-ksn.org/upload/pdf/j-krcp-22-118.pdf |